Curated Resources — Long term outcome of Progressive Multifocal Leukoencephalopathy after Tysabri exposure

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Featured analysis

Long term outcome of Progressive Multifocal Leukoencephalopathy after Tysabri exposure: Key Facts & Context

A focused review of background, context, and source material on this subject.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.

World Health Organization (WHO)

Reference: World Health Organization (WHO)

Authoritative source for clinical, regulatory, and public-health background reading.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.